BR0317349A - Droga sólida para uso oral - Google Patents
Droga sólida para uso oralInfo
- Publication number
- BR0317349A BR0317349A BR0317349-6A BR0317349A BR0317349A BR 0317349 A BR0317349 A BR 0317349A BR 0317349 A BR0317349 A BR 0317349A BR 0317349 A BR0317349 A BR 0317349A
- Authority
- BR
- Brazil
- Prior art keywords
- solid drug
- oral use
- pharmaceutically acceptable
- elution
- prodrug
- Prior art date
Links
- 229940079593 drug Drugs 0.000 title abstract 3
- 239000003814 drug Substances 0.000 title abstract 3
- 239000007787 solid Substances 0.000 title abstract 3
- 238000010828 elution Methods 0.000 abstract 3
- 238000000034 method Methods 0.000 abstract 2
- 238000012360 testing method Methods 0.000 abstract 2
- 230000000903 blocking effect Effects 0.000 abstract 1
- -1 indoline compound Chemical class 0.000 abstract 1
- 229940002612 prodrug Drugs 0.000 abstract 1
- 239000000651 prodrug Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
- 230000002485 urinary effect Effects 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/04—Drugs for disorders of the urinary system for urolithiasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
Abstract
"DROGA SóLIDA PARA USO ORAL". A presente invenção pretende proporcionar uma droga sólida para ser usada por via oral para o tratamento de distúrbios urinários que contenham um composto de indolina dotado de um efeito de bloqueio de receptor <244>1-adrenérgico, e sendo representado pela fórmula a seguir; a sua prodroga, um sal farmaceuticamente aceitável do mesmo ou um solvato farmaceuticamente aceitável do mesmo, e é preparada de modo a apresentar um tempo de elução de 85% não superior a 60 minutos no teste de elução em água, de acordo com o segundo método de teste de elução (o método de espátula) na Farmacopéia Japonesa.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2002364238 | 2002-12-16 | ||
PCT/JP2003/015837 WO2004054574A1 (ja) | 2002-12-16 | 2003-12-11 | 経口固形医薬 |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0317349A true BR0317349A (pt) | 2005-11-16 |
Family
ID=32588229
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0317349-6A BR0317349A (pt) | 2002-12-16 | 2003-12-11 | Droga sólida para uso oral |
Country Status (24)
Country | Link |
---|---|
US (2) | US20060018959A1 (pt) |
EP (2) | EP1574215B1 (pt) |
JP (1) | JP4633469B2 (pt) |
KR (2) | KR101072909B1 (pt) |
CN (2) | CN101069685B (pt) |
AU (1) | AU2003289320C1 (pt) |
BR (1) | BR0317349A (pt) |
CA (1) | CA2507002C (pt) |
EA (1) | EA008196B1 (pt) |
ES (1) | ES2544560T3 (pt) |
HK (2) | HK1085131A1 (pt) |
HR (1) | HRP20050544B1 (pt) |
IL (1) | IL169040A (pt) |
IS (1) | IS7929A (pt) |
ME (2) | ME00076B (pt) |
MX (1) | MXPA05006513A (pt) |
NO (1) | NO20053467L (pt) |
NZ (1) | NZ540664A (pt) |
PL (1) | PL220457B1 (pt) |
RS (1) | RS58025B1 (pt) |
TW (2) | TWI382838B (pt) |
UA (2) | UA84694C2 (pt) |
WO (1) | WO2004054574A1 (pt) |
ZA (1) | ZA200504613B (pt) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1930123B (zh) * | 2004-03-05 | 2010-06-23 | 橘生药品工业株式会社 | 用于预防或治疗伴有神经障碍的膀胱过度活动症的医药组合物 |
EP1800677A4 (en) * | 2004-10-05 | 2008-04-02 | Kissei Pharmaceutical | AGENT FOR THE PROPHYLACTIC OR THERAPEUTIC TREATMENT OF URINE COLLECTION DISORDERS IN BLADDER OF THE BLADDER OF THE LOWER URINARY CANAL |
MX2009009230A (es) * | 2007-02-28 | 2009-11-26 | Kissei Pharmaceutical | Uso de silodosina en una administracion diaria para tratar hiperplasia prostatica benigna. |
JP5432720B2 (ja) * | 2007-03-13 | 2014-03-05 | 武田薬品工業株式会社 | 2−[[6−[(3r)−3−アミノ−1−ピペリジニル]−3,4−ジヒドロ−3−メチル−2,4−ジオキソ−1(2h)−ピリミジニル]メチル]−4−フルオロベンゾニトリルを含む固形製剤 |
ES2471076T3 (es) | 2010-06-28 | 2014-06-25 | Ratiopharm Gmbh | Compuestos de inclusión de silodoxina-ciclodextrina |
JP2013532651A (ja) | 2010-07-23 | 2013-08-19 | ラティオファルム ゲー・エム・ベー・ハー | シロドシンと塩基性コポリマーとの混合物を含む経口投与用医薬品 |
PL2474529T3 (pl) | 2010-12-23 | 2014-10-31 | Sandoz Ag | Formy krystaliczne farmaceutycznej substancji czynnej |
CN102283816B (zh) * | 2011-08-05 | 2013-09-11 | 北京海步国际医药科技发展有限公司 | 西洛多辛缓释片剂及其制备方法 |
WO2013061338A1 (en) | 2011-08-24 | 2013-05-02 | Cadila Healthcare Limited | Pharmaceutical compositions of silodosin |
JP6031722B2 (ja) * | 2011-08-31 | 2016-11-24 | 国立大学法人 千葉大学 | 女性の排尿障害の治療剤 |
KR20140138725A (ko) * | 2012-02-16 | 2014-12-04 | 테바 파마슈티컬 인더스트리즈 리미티드 | N-에틸-n-페닐-1,2-디하이드로-4,5-디-하이드록시-1-메틸-2-옥소-3-퀴놀린카복사미드, 그의 제조 및 용도 |
US8883823B2 (en) | 2012-07-16 | 2014-11-11 | Fibrogen, Inc. | Crystalline forms of a prolyl hydroxylase inhibitor |
PT2872488T (pt) | 2012-07-16 | 2018-11-22 | Fibrogen Inc | Formas cristalinas do ácido [(4-hidroxi-1-metil-7-fenoxi-isoquinolina-3-carbonil)amino]acético inibidor da prolil-hidroxilase |
CN105142633A (zh) | 2013-03-26 | 2015-12-09 | 橘生药品工业株式会社 | 西洛多辛苦味被掩蔽的口服给药制剂 |
WO2014197660A1 (en) | 2013-06-06 | 2014-12-11 | Fibrogen, Inc. | Pharmaceutical formulations of a hif hydroxylase inhibitor |
KR102206104B1 (ko) | 2014-04-03 | 2021-01-22 | 한미약품 주식회사 | 실로도신을 포함하는 과립물, 및 이를 포함하는 약학적 조성물 및 제형 |
CN103933001A (zh) * | 2014-05-09 | 2014-07-23 | 浙江华海药业股份有限公司 | 一种稳定的赛洛多辛口服固体药物组合物及其制备方法 |
CN105435233B (zh) * | 2014-08-06 | 2018-05-01 | 江苏正大丰海制药有限公司 | 一种英加韦林的药物组合物 |
JP6366547B2 (ja) * | 2015-08-03 | 2018-08-01 | 大原薬品工業株式会社 | 光安定性が向上した、プラミペキソール製剤包装体 |
CN108685867A (zh) * | 2017-04-06 | 2018-10-23 | 昆明积大制药股份有限公司 | 一种赛洛多辛薄膜衣片及其制备方法 |
EP3354283B1 (en) | 2017-06-20 | 2019-08-07 | Alfred E. Tiefenbacher (GmbH & Co. KG) | Pharmaceutical capsule composition comprising silodosin |
CN111437260A (zh) * | 2019-01-17 | 2020-07-24 | 北京万全德众医药生物技术有限公司 | 用于制备盐酸美金刚固态药物组合物的方法 |
JP7262005B2 (ja) * | 2019-01-25 | 2023-04-21 | 日本ジェネリック株式会社 | シロドシン含有固形組成物及びその製造法 |
CN114601826A (zh) * | 2022-03-31 | 2022-06-10 | 乐泰药业有限公司 | 一种用于治疗前列腺增生的药物制剂及其制备方法和质量检测方法 |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1060073A (en) | 1963-03-02 | 1967-02-22 | Benger Lab Ltd | 2,2,2-trichlorethyl hydrogen succinate and salts |
US4547498A (en) | 1983-01-06 | 1985-10-15 | Mylan Pharmaceuticals Inc. | Pharmaceutical combination composition and associated method |
US4757090A (en) * | 1986-07-14 | 1988-07-12 | Mallinckrodt, Inc. | Direct tableting acetaminophen compositions |
HU200926B (en) * | 1988-10-28 | 1990-09-28 | Egyt Gyogyszervegyeszeti Gyar | Pharmaceutical composition comprising piroxicam and lactose for use in making tablets or capsules |
DE69319551T2 (de) * | 1992-12-02 | 1998-10-29 | Kissei Pharmaceutical | Indolin Verbindungen zur Behandlung von Dysurien |
US5370878A (en) * | 1993-09-30 | 1994-12-06 | Hallmark Pharmaceuticals, Inc. | Method for preparing a direct compression granulated acetaminophen composition |
ES2163504T5 (es) | 1994-05-06 | 2008-05-16 | Pfizer Inc. | Formas de dosificacion de liberacion controlada de azitromicina. |
ES2125198B1 (es) * | 1997-05-13 | 1999-11-16 | Vita Invest Sa | Asociacion a dosis fija de un inhibidor de la enzima convertidora de angiotensina y de un antagonista de los canales de calcio, procedimiento para su preparacion y su utilizacion para el tratamiento de enfermees cardiovasculares. |
AR016827A1 (es) | 1997-08-22 | 2001-08-01 | Smithkline Beecham Corp | PROCEDIMIENTO PARA LA PREPARACIoN DE UNA TABLETA FARMACÉUTICA |
WO1999015202A1 (fr) * | 1997-09-22 | 1999-04-01 | Kissei Pharmaceutical Co., Ltd. | Medicaments contre la dysurie resultant d'une hypertrophie de la prostate |
US20020177593A1 (en) * | 1998-09-30 | 2002-11-28 | Yuji Ishihara | Agents and crystals for improving excretory potency of urinary bladder |
JP4324266B2 (ja) * | 1999-02-26 | 2009-09-02 | キッセイ薬品工業株式会社 | α1Aアドレナリン受容体の変異体、当該変異体を用いた測定方法及び前立腺肥大に伴う排尿困難症治療剤 |
US20010053780A1 (en) | 1999-04-30 | 2001-12-20 | Whitaker John S. | Daily treatment for erectile dysfunction using a PDE5 inhibitor |
JP4014068B2 (ja) * | 1999-07-28 | 2007-11-28 | 芦森工業株式会社 | エアバッグ装置 |
PE20011178A1 (es) * | 2000-04-07 | 2001-11-19 | Takeda Chemical Industries Ltd | Compuestos heterociclicos y su produccion |
EP1293206A4 (en) | 2000-05-15 | 2005-09-21 | Kissei Pharmaceutical | LIQUID PREPARATION BASED ON WATER |
RS51449B (sr) * | 2001-01-26 | 2011-04-30 | Schering Corporation | Kombinacija aktivatora peroksizom proliferator-aktiviranog receptora (ppar) i inhibitora apsorpcije sterola i lečenje vaskularnih indikacija |
JP2001288115A (ja) | 2001-02-07 | 2001-10-16 | Yamanouchi Pharmaceut Co Ltd | 下部尿路症治療剤 |
JPWO2002069957A1 (ja) * | 2001-03-01 | 2004-07-02 | グレラン製薬株式会社 | フェノフィブラート含有組成物 |
US6786714B2 (en) * | 2001-04-12 | 2004-09-07 | James W. Haskew | Delivery system for liquid catalysts |
GB0113843D0 (en) | 2001-06-07 | 2001-08-01 | Boots Co Plc | Therapeutic agents |
UA78854C2 (en) * | 2002-09-06 | 2007-04-25 | Kissei Pharmaceutical | Crystal for an oral solid drug and oral solid drug for dysuria treatment containing the same |
-
2003
- 2003-12-11 BR BR0317349-6A patent/BR0317349A/pt not_active Application Discontinuation
- 2003-12-11 WO PCT/JP2003/015837 patent/WO2004054574A1/ja active Application Filing
- 2003-12-11 UA UAA200507046A patent/UA84694C2/ru unknown
- 2003-12-11 KR KR1020057010977A patent/KR101072909B1/ko active IP Right Grant
- 2003-12-11 PL PL377495A patent/PL220457B1/pl unknown
- 2003-12-11 EP EP03780719.5A patent/EP1574215B1/en not_active Revoked
- 2003-12-11 ES ES03780719.5T patent/ES2544560T3/es not_active Expired - Lifetime
- 2003-12-11 RS YU20050470A patent/RS58025B1/sr unknown
- 2003-12-11 ME MEP-2008-108A patent/ME00076B/me unknown
- 2003-12-11 AU AU2003289320A patent/AU2003289320C1/en active Active
- 2003-12-11 EP EP11007870A patent/EP2402010A1/en not_active Withdrawn
- 2003-12-11 CN CN2007100840362A patent/CN101069685B/zh not_active Expired - Lifetime
- 2003-12-11 EA EA200500985A patent/EA008196B1/ru unknown
- 2003-12-11 US US10/538,514 patent/US20060018959A1/en not_active Abandoned
- 2003-12-11 UA UAA200809667A patent/UA85359C2/ru unknown
- 2003-12-11 CN CNB2003801062486A patent/CN100339078C/zh not_active Ceased
- 2003-12-11 JP JP2004560618A patent/JP4633469B2/ja not_active Expired - Lifetime
- 2003-12-11 KR KR1020107026925A patent/KR101077061B1/ko active IP Right Grant
- 2003-12-11 MX MXPA05006513A patent/MXPA05006513A/es active IP Right Grant
- 2003-12-11 ME MEP-108/08A patent/MEP10808A/xx unknown
- 2003-12-11 CA CA2507002A patent/CA2507002C/en not_active Expired - Lifetime
- 2003-12-11 NZ NZ540664A patent/NZ540664A/en not_active IP Right Cessation
- 2003-12-15 TW TW098121810A patent/TWI382838B/zh not_active IP Right Cessation
- 2003-12-15 TW TW092135358A patent/TWI325318B/zh not_active IP Right Cessation
-
2005
- 2005-06-06 ZA ZA200504613A patent/ZA200504613B/en unknown
- 2005-06-07 IL IL169040A patent/IL169040A/en active IP Right Grant
- 2005-06-14 HR HRP20050544AA patent/HRP20050544B1/hr not_active IP Right Cessation
- 2005-07-01 IS IS7929A patent/IS7929A/is unknown
- 2005-07-15 NO NO20053467A patent/NO20053467L/no not_active Application Discontinuation
-
2006
- 2006-05-08 HK HK06105339A patent/HK1085131A1/xx not_active IP Right Cessation
- 2006-05-08 HK HK08101016.0A patent/HK1107768A1/xx not_active IP Right Cessation
-
2011
- 2011-11-03 US US13/288,348 patent/US20120064154A1/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0317349A (pt) | Droga sólida para uso oral | |
ES2354417T3 (es) | Nuevo uso de una clase de compuestos peptídicos para tratar alodinia u otros tipos diferentes de dolor crónico o fantasma. | |
BR0312095A (pt) | Composto, composição farmacêutica, e, uso de um composto | |
BRPI0108380A8 (pt) | fórmulas de opióides agonistas resistentes à adulteração, método para diminuir o abuso de um opióide agonista numa fórmula de dosagem oral, método de preparação de uma fórmula de dosagem oral e método de tratamento da dor | |
MY142204A (en) | Pramipexole once-daily dosage form | |
BRPI0409417A (pt) | método para usar um composto, composto, e, composição | |
BR0308816A (pt) | Tiazolidina-4-carbonitrilas e análogos e seus usos como inibidores da dipeptil-peptidas | |
ES8505519A1 (es) | Un procedimiento para la preparacion de 14-fluoromorfinanos utiles como analgesicos, narcoticos y-o agentes anorexicos. | |
BR0317149A (pt) | Métodos para uso de uma composição para bebidas | |
NO20076319L (no) | Farmasoytiske sammensetninger av et neuroaktivt steroid og anvendelse derav | |
BRPI0518231A2 (pt) | derivados de 2-amido-4-feniltiazol, o respectivo preparo e a respectiva aplicaÇço em terapÊutica | |
CA2318095A1 (en) | Methods of treating tardive dyskinesia and other movement disorders | |
BR9909138A (pt) | Combinação para o tratamento de dependência de álcool e drogas contendo um antagonista de opióide e um modulador de complexo receptor de nmda | |
IS8096A (is) | Notkun karbamasepínafleiða til að meðhöndla órósemi í sjúklingum er þjást af vitglöpum | |
BR9915111A (pt) | Partìculas revestidas de ibuprofeno cristalinogranulado | |
BR0206237A (pt) | Uso de um composto de carboestiril | |
BRPI0413013A (pt) | composto, seus sais, solvatos, e derivados farmaceuticamente funcionais, composição farmacêutica, uso de um composto, e, métodos para o tratamento ou profilaxia de condições ou distúrbios, e de doenças | |
NO20050903L (no) | Nye piperazinyl-pyrazinonderivater for behandling av 5HT-2A reseptorrelaterte forstyrrelser | |
HUP0204511A2 (en) | Use of ppar activator or ligand in preparation of pharmaceutical compositions for treatment of bone diseas | |
Al-Zahrani et al. | Clinical manifestations of gastrointestinal diseases in the oral cavity | |
ATE73449T1 (de) | 2-piperazinyl-2-oxo-aethylensubstituierte flavonoid-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammenstellungen. | |
BR0015172A (pt) | Nova combinação compreendendo um agonista adreno receptor de beta 2 (beta 2) e um antagonista receptor de leucotrieno | |
BR0008057A (pt) | Forma cristalina de eplerenona apresentando velocidade de dissolução intensificada | |
BR0316131A (pt) | Acetil-l-carnitina para a prevenção e/ou tratamento de neuropatias periféricas induzidas por agentes anti-câncer | |
BR0215064A (pt) | Agonistas receptores seletivos de dopamina d3 para o tratamento de disfunção sexual |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: INDEFIRO O PEDIDO DE ACORDO COM OS ARTIGOS 8O, 13 E 25 DA LPI. |
|
B12B | Appeal against refusal [chapter 12.2 patent gazette] |